{"id":"NCT01648582","sponsor":"Eli Lilly and Company","briefTitle":"A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus","officialTitle":"The Efficacy and Safety of Once-Weekly, Subcutaneous Dulaglutide Compared to Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Mellitus on Metformin and/or a Sulfonylurea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07","primaryCompletion":"2014-08","completion":"2014-12","firstPosted":"2012-07-24","resultsPosted":"2015-07-24","lastUpdate":"2019-09-18"},"enrollment":774,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Dulaglutide","otherNames":["LY2189265"]},{"type":"DRUG","name":"Insulin glargine","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Sulfonylureas","otherNames":[]}],"arms":[{"label":"1.5 mg Dulaglutide","type":"EXPERIMENTAL"},{"label":"0.75 mg Dulaglutide","type":"EXPERIMENTAL"},{"label":"Insulin Glargine","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to examine if once-weekly dulaglutide is efficient and safe compared to once-daily insulin glargine in participants with type 2 diabetes mellitus who have inadequate glycemic control with 1 or 2 oral antihyperglycemic medications (OAM) (metformin and/or a sulfonylurea), in addition to any healthy lifestyle changes recommended by their healthcare providers.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c) at 26 Weeks","timeFrame":"Baseline, 26 Weeks","effectByArm":[{"arm":"1.5 mg Dulaglutide","deltaMin":-1.73,"sd":0.067},{"arm":"0.75 mg Dulaglutide","deltaMin":-1.33,"sd":0.067},{"arm":"Insulin Glargine","deltaMin":-1.16,"sd":0.067}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":11},"locations":{"siteCount":30,"countries":["China","Mexico","Russia","South Korea"]},"refs":{"pmids":["34580638","34453682","33161492","32857293","32621083","32277401","31950036","31228090"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":258},"commonTop":["Hyperlipidaemia","Diarrhoea","Hypertension","Nasopharyngitis","Lipase increased"]}}